Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Buy

Wall Street Data Solutions Rating

Neutral

B

REGENXBIO Inc. (RGNX)

Biological Products, (no Disgnostic Substances)

https://www.regenxbio.com

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa).

9804 MEDICAL CENTER DRIVE
ROCKVILLE, MD

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

09/17/2015

Market Cap

604,939,968

Shares Outstanding

43,990,000

Weighted SO

43,991,980

Total Employees

N/A

Upcoming Earnings

08/07/2024

Similar Tickers

DAWN --.--%

REPL --.--%

MIRM --.--%

RCKT --.--%

RNA --.--%

QURE --.--%

PTGX --.--%

PLRX --.--%

IMCR --.--%

Beta

1.2630

Last Div

0.0000

Range

10.49-28.8

Chg

-0.1700

Avg Vol

577122

Mkt Cap

604939968

Exch

NASDAQ

Country

US

Phone

240 552 8181

DCF Diff

39.1170

DCF

-19.0970

Div Yield

0.0000

P/S

6.7937

EV Multiple

-3.0161

P/FV

1.7784

Div Yield %

0.0000

P/E

-2.5691

PEG

-0.0988

Payout

0.0000

Current Ratio

3.5278

Quick Ratio

3.5278

Cash Ratio

0.5878

DSO

99.1818

DIO

0.0000

Op Cycle

99.1818

DPO

116.9767

CCC

-17.7950

Gross Margin

0.4266

Op Margin

-2.7701

Pretax Margin

-2.7091

Net Margin

-2.7074

Eff Tax Rate

0.0120

ROA

-0.4234

ROE

-0.6821

ROCE

-0.5236

NI/EBT

0.9994

EBT/EBIT

0.9780

EBIT/Rev

-2.7701

Debt Ratio

0.1413

D/E

0.2311

LT Debt/Cap

0.1055

Total Debt/Cap

0.1877

Int Coverage

-54.6801

CF/Debt

-2.3747

Equity Multi

1.6349

Rec Turnover

3.6801

Pay Turnover

3.1203

Inv Turnover

0.0000

FA Turnover

0.4938

Asset Turnover

0.1564

OCF/Share

-3.7770

FCF/Share

-3.8480

Cash/Share

5.7382

OCF/Sales

-2.1463

FCF/OCF

1.0188

CF Coverage

-2.3747

ST Coverage

-4.8505

CapEx Coverage

-53.1477

Div&CapEx Cov

-53.1477

P/BV

1.7784

P/B

1.7784

P/S

6.7937

P/E

-2.5691

P/FCF

-3.1068

P/OCF

-3.2407

P/CF

-3.2407

PEG

-0.0988

P/S

6.7937

EV Multiple

-3.0161

P/FV

1.7784

DPS

0.0000

Latest Headlines (EST)

Benzinga Jan 17, 15:28 Ocular Gene Therapy: Regenxbio Data Shows Consistent Preservation Of Visual Acuity, Retinal Thickness

Revenue Product Segmentation